The Wisconsin epidemiologic study of diabetic retinopathy: an update
- PMID: 2357354
- DOI: 10.1111/j.1442-9071.1990.tb00579.x
The Wisconsin epidemiologic study of diabetic retinopathy: an update
Abstract
Population-based epidemiologic data on the incidence and progression of diabetic retinopathy are important in developing approaches to preventing diabetic retinopathy, in medical counselling and rehabilitative services. The objectives of the Wisconsin Epidemiological Study of Diabetic Retinopathy were as follows: (1) to describe the prevalence, incidence, and progression of diabetic retinopathy and its component lesions, and to determine the incidence of visual impairment in a large population-based cohort; and (2) to determine the relationships between incidence and progression of diabetic retinopathy and risk factors in this cohort. Grading of stereoscopic fundus photographs was performed at the University of Wisconsin Fundus Photograph Reading Centre for photographs from both the baseline examination in 1980-1982 and follow-up examination four years later. Insulin-taking persons diagnosed to have diabetes before 30 years of age had the highest prevalence (71%), four-year incidence (59%) and progression to proliferative diabetic retinopathy (11%) while older-onset persons diagnosed to have diabetes at or after 30 years of age and not using insulin had the lowest prevalence (39%), incidence (34%) and progression to proliferative diabetic retinopathy (3%). These incidence data indicate that a substantial proportion of older onset diabetic people, a group previously thought to be protected from retinopathy, developed it during the four-year interval and underscores the need for careful ophthalmologic examination.
Similar articles
-
The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy.Arch Ophthalmol. 1994 Sep;112(9):1217-28. doi: 10.1001/archopht.1994.01090210105023. Arch Ophthalmol. 1994. PMID: 7619101
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.Arch Ophthalmol. 1989 Feb;107(2):237-43. doi: 10.1001/archopht.1989.01070010243030. Arch Ophthalmol. 1989. PMID: 2916977
-
HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy.Ophthalmology. 2002 Feb;109(2):275-81. doi: 10.1016/s0161-6420(01)00925-3. Ophthalmology. 2002. PMID: 11825808
-
Epidemiology of proliferative diabetic retinopathy.Diabetes Care. 1992 Dec;15(12):1875-91. doi: 10.2337/diacare.15.12.1875. Diabetes Care. 1992. PMID: 1464243 Review.
-
The Wisconsin epidemiological study of diabetic retinopathy: a review.Diabetes Metab Rev. 1989 Nov;5(7):559-70. doi: 10.1002/dmr.5610050703. Diabetes Metab Rev. 1989. PMID: 2689119 Review.
Cited by
-
Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.Diabetes Care. 2011 Nov;34(11):2368-73. doi: 10.2337/dc11-0102. Diabetes Care. 2011. PMID: 22025782 Free PMC article.
-
Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.BMJ Clin Evid. 2016 Mar 16;2016:0702. BMJ Clin Evid. 2016. PMID: 27031563 Free PMC article. Review.
-
Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality.PLoS One. 2016 Apr 6;11(4):e0153033. doi: 10.1371/journal.pone.0153033. eCollection 2016. PLoS One. 2016. PMID: 27050468 Free PMC article.
-
Visfatin promotes angiogenesis of RF/6A cells through upregulation of VEGF/VEGFR-2 under high-glucose conditions.Exp Ther Med. 2021 Apr;21(4):389. doi: 10.3892/etm.2021.9820. Epub 2021 Feb 24. Exp Ther Med. 2021. PMID: 33680111 Free PMC article.
-
Diabetic retinopathy.Clin Ophthalmol. 2007 Sep;1(3):259-65. Clin Ophthalmol. 2007. PMID: 19668479 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical